Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated:  9/27/2013
Nationwide Children's Hospital
2
mi
from 43215
Columbus, OH
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Nationwide Children's Hospital
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated:  9/27/2013
University of Oklahoma
848
mi
from 43215
Oklahoma City, OK
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
University of Oklahoma
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated:  9/27/2013
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated:  9/27/2013
Vanderbilt University
331
mi
from 43215
Nashville, TN
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
Vanderbilt University
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated:  9/27/2013
University of Texas, San Antonio
1136
mi
from 43215
San Antonio, TX
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
University of Texas, San Antonio
1136
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated:  9/27/2013
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Telemedicine Approaches to Evaluating Acute-phase ROP
Telemedicine Approaches to Evaluating Acute-phase ROP
Status: Enrolling
Updated: 9/27/2013
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of a New Daily Disposable Multifocal Contact Lens Design
Delefilcon A Multifocal Plus Power Lens Design Evaluation
Status: Enrolling
Updated:  10/9/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Evaluation of a New Daily Disposable Multifocal Contact Lens Design
Delefilcon A Multifocal Plus Power Lens Design Evaluation
Status: Enrolling
Updated: 10/9/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses
Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated:  10/17/2013
University of California, Berkeley Clinical Research Center (UCB-CRC)
2099
mi
from 43215
Berkeley, CA
Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses
Clinical Evaluation of Hydrogels vs Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 10/17/2013
University of California, Berkeley Clinical Research Center (UCB-CRC)
2099
mi
from 43215
Berkeley, CA
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Sall Research Medical Center, Inc.
1968
mi
from 43215
Artesia, CA
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Sall Research Medical Center, Inc.
1968
mi
from 43215
Artesia, CA
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
North Bay Eye
2109
mi
from 43215
Petaluma, CA
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
North Bay Eye
2109
mi
from 43215
Petaluma, CA
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Martel Medical Eye Group
2033
mi
from 43215
Rancho Cardova, CA
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Martel Medical Eye Group
2033
mi
from 43215
Rancho Cardova, CA
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Specialty Eye Care
1152
mi
from 43215
Parker, CO
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Specialty Eye Care
1152
mi
from 43215
Parker, CO
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
International Research Center
828
mi
from 43215
Brandon, FL
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
International Research Center
828
mi
from 43215
Brandon, FL
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
East Florida Eye Institute
896
mi
from 43215
Stuart, FL
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
East Florida Eye Institute
896
mi
from 43215
Stuart, FL
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Clayton Eye Center
446
mi
from 43215
Morrow, GA
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Clayton Eye Center
446
mi
from 43215
Morrow, GA
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Coastal Research Associates, LLC
417
mi
from 43215
Roswell, GA
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Coastal Research Associates, LLC
417
mi
from 43215
Roswell, GA
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Chicago Research Center, Inc
284
mi
from 43215
Chicago, IL
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Chicago Research Center, Inc
284
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Chicago Cornea Consultants, LTD
302
mi
from 43215
Hoffman Estates, IL
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Chicago Cornea Consultants, LTD
302
mi
from 43215
Hoffman Estates, IL
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Koffler Vision Group
204
mi
from 43215
Lebanon, KY
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Koffler Vision Group
204
mi
from 43215
Lebanon, KY
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Taustine Eye Center
189
mi
from 43215
Louisville, KY
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Taustine Eye Center
189
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Comprehensive Eye Care, Ltd/Vision Research Institute, LLC
438
mi
from 43215
Washington, MO
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Comprehensive Eye Care, Ltd/Vision Research Institute, LLC
438
mi
from 43215
Washington, MO
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Charlotte Eye, Ear, Nose & Throat Associates
354
mi
from 43215
Charlotte, NC
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Charlotte Eye, Ear, Nose & Throat Associates
354
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Mundorf Eye Center
348
mi
from 43215
Charlotte, NC
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Mundorf Eye Center
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Cornerstone Eyecare
320
mi
from 43215
High Point, NC
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Cornerstone Eyecare
320
mi
from 43215
High Point, NC
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Abrams Eye Center
127
mi
from 43215
Cleveland, OH
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Abrams Eye Center
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Glaucoma Consultants and Center for Eye Research
523
mi
from 43215
Mt. Pleasant, SC
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Glaucoma Consultants and Center for Eye Research
523
mi
from 43215
Mt. Pleasant, SC
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Chattanooga Eye Institute
355
mi
from 43215
Chattanooga, TN
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Chattanooga Eye Institute
355
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated:  10/22/2013
Eye Clinics of South Texas
1135
mi
from 43215
San Antonio, TX
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Status: Enrolling
Updated: 10/22/2013
Eye Clinics of South Texas
1135
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients
A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients
Status: Enrolling
Updated:  10/25/2013
William Beaumont Hospital-Royal Oak
176
mi
from 43215
Royal Oak, MI
A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients
A Comparison of Intraocular Pressures (IOP) During Prolonged Trendelenburg Positioning in Morbidly Obese and Thin Patients
Status: Enrolling
Updated: 10/25/2013
William Beaumont Hospital-Royal Oak
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials
Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact Lenses
Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated:  10/29/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact Lenses
Clinical Evaluation of Two Monthly Replacement Silicone Hydrogel Contact Lenses
Status: Enrolling
Updated: 10/29/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Effect of SIMBRINZA™ As an Added Therapy to TRAVATAN Z®
Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination As Adjunctive Therapy to Travoprost
Status: Enrolling
Updated:  10/29/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Effect of SIMBRINZA™ As an Added Therapy to TRAVATAN Z®
Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination As Adjunctive Therapy to Travoprost
Status: Enrolling
Updated: 10/29/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Effect of SIMBRINZA™ As an Added Therapy to a Prostaglandin Analogue
Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue
Status: Enrolling
Updated:  10/29/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Effect of SIMBRINZA™ As an Added Therapy to a Prostaglandin Analogue
Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue
Status: Enrolling
Updated: 10/29/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Lacrimal Drainage Resistance Study
Lacrimal Drainage Resistance Study
Status: Enrolling
Updated:  10/30/2013
Cleveland Clinic - Cole Eye Institute
138
mi
from 43215
Cleveland, OH
Lacrimal Drainage Resistance Study
Lacrimal Drainage Resistance Study
Status: Enrolling
Updated: 10/30/2013
Cleveland Clinic - Cole Eye Institute
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
Status: Enrolling
Updated:  11/1/2013
Contact Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
Status: Enrolling
Updated: 11/1/2013
Contact Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Status: Enrolling
Updated:  11/7/2013
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Metabolic Screening in Patients With Donnai-Barrow Syndrome
Status: Enrolling
Updated: 11/7/2013
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension.
Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination Therapy
Status: Enrolling
Updated:  11/8/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension.
Prospective, Randomized, Single-Center Study to Evaluate 24-hour Intraocular Pressure Control With Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination Therapy
Status: Enrolling
Updated: 11/8/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
Phase 4 Study of Intravitreal Aflibercept Injection for Recalcitrant Central Retinal Vein Occlusion Associated Macular Edema Despite Prior Anti-Vascular Endothelial Growth Factor (VEGF) Therapy. (ARChiMEDES)
Status: Enrolling
Updated:  11/18/2013
Tennessee Retina, P.C.
333
mi
from 43215
Nashville, TN
Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
Phase 4 Study of Intravitreal Aflibercept Injection for Recalcitrant Central Retinal Vein Occlusion Associated Macular Edema Despite Prior Anti-Vascular Endothelial Growth Factor (VEGF) Therapy. (ARChiMEDES)
Status: Enrolling
Updated: 11/18/2013
Tennessee Retina, P.C.
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Investigation of IOP Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Status: Enrolling
Updated:  11/21/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Investigation of IOP Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Status: Enrolling
Updated: 11/21/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Effect of Blue Light Filtration on Visual Performance
Effect of Blue Light Filtration on Visual Performance
Status: Enrolling
Updated:  11/22/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Effect of Blue Light Filtration on Visual Performance
Effect of Blue Light Filtration on Visual Performance
Status: Enrolling
Updated: 11/22/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty
Status: Enrolling
Updated:  11/23/2013
Price Vision Group
167
mi
from 43215
Indianapolis, IN
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty
Status: Enrolling
Updated: 11/23/2013
Price Vision Group
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients
Status: Enrolling
Updated:  12/4/2013
Contact Alcon for Trial Locations
937
mi
from 43215
Fort Worth, TX
An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients
Status: Enrolling
Updated: 12/4/2013
Contact Alcon for Trial Locations
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Safety Study of Latanoprost Slow Release Insert
A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  12/5/2013
Univ of Ky
154
mi
from 43215
Lexington, KY
Safety Study of Latanoprost Slow Release Insert
A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 12/5/2013
Univ of Ky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Safety Study of Latanoprost Slow Release Insert
A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated:  12/5/2013
University of Kentucky
154
mi
from 43215
Lexington, KY
Safety Study of Latanoprost Slow Release Insert
A Phase 1, Open-label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release (SR) Insert in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status: Enrolling
Updated: 12/5/2013
University of Kentucky
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Intra-Operative Metrics With CENTURION and INFINITI Vision Systems
Intra-Operative Metrics and Clinical Outcomes After Cataract Surgery With the CENTURION Vision System and the INFINITI Vision System
Status: Enrolling
Updated:  12/24/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Intra-Operative Metrics With CENTURION and INFINITI Vision Systems
Intra-Operative Metrics and Clinical Outcomes After Cataract Surgery With the CENTURION Vision System and the INFINITI Vision System
Status: Enrolling
Updated: 12/24/2013
Alcon Call Center
941
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Status: Enrolling
Updated:  1/3/2014
Martel Eye Medical Group
2033
mi
from 43215
Rancho Cordova, CA
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Status: Enrolling
Updated: 1/3/2014
Martel Eye Medical Group
2033
mi
from 43215
Rancho Cordova, CA
Click here to add this to my saved trials
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Status: Enrolling
Updated:  1/3/2014
Cincinnati Eye Institute
105
mi
from 43215
Edgewood, KY
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Status: Enrolling
Updated: 1/3/2014
Cincinnati Eye Institute
105
mi
from 43215
Edgewood, KY
Click here to add this to my saved trials
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Status: Enrolling
Updated:  1/3/2014
Associated Eye Care
609
mi
from 43215
Stillwater, MN
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
Status: Enrolling
Updated: 1/3/2014
Associated Eye Care
609
mi
from 43215
Stillwater, MN
Click here to add this to my saved trials
Safety Study Looking at the Effects of Stendra on Vision
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Parallel Study to Assess the Effects of Avanafil (STENDRA™) on Multiple Parameters of Vision, Including, But Not Limited to Visual Acuity, Intraocular Pressure, Pupillometry, and Color Vision Discrimination, in Healthy Male Subjects
Status: Enrolling
Updated:  1/9/2014
Celerion
1657
mi
from 43215
Tempe, AZ
Safety Study Looking at the Effects of Stendra on Vision
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Parallel Study to Assess the Effects of Avanafil (STENDRA™) on Multiple Parameters of Vision, Including, But Not Limited to Visual Acuity, Intraocular Pressure, Pupillometry, and Color Vision Discrimination, in Healthy Male Subjects
Status: Enrolling
Updated: 1/9/2014
Celerion
1657
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/13/2014
Clinical Research Facility
1968
mi
from 43215
Artesia, CA
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/13/2014
Clinical Research Facility
1968
mi
from 43215
Artesia, CA
Click here to add this to my saved trials
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  1/13/2014
Clinical Research Facility
1425
mi
from 43215
El Paso, TX
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 1/13/2014
Clinical Research Facility
1425
mi
from 43215
El Paso, TX
Click here to add this to my saved trials